Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Search by expertise, name or affiliation
RGN-1652: A Randomized, Double-Blind, Placebo-Controlled, Study to Investigate the Efficacy and Safety of Dupilumab Administered Concomitantly with Topical Corticosteroids in Patients >= 6 years to <12 years of age, with Severe
Effective start/end date
Regeneron Pharmaceuticals, Inc.